NOW APPROVED
in Adults with
PRURIGO NODULARIS (PN)
DUPIXENT is a prescription medicine used
to treat adults with prurigo nodularis (PN).
It is not known if DUPIXENT is safe and
effective in children with prurigo nodularis
under 18 years of age.
DUPIXENT can help control
a source of unwanted
inflammation which could
be a driver of your PN
Proven results*
~3x as many adults had significantly
less itch at 24 weeks
(In trial 1, 60% on DUPIXENT vs 18.4% on placebo; in trial 2, 57.7% on
DUPIXENT vs 19.5% on placebo)
Some adults had less itch in as little as
12 weeks
(In trial 2, 37.2% on DUPIXENT vs 22% on placebo)
~3x as many adults had skin that's
clear or almost clear of PN bumps at
24 weeks
(In trial 1, 48% on DUPIXENT vs 18.4% on placebo; in trial 2,
44.9% on DUPIXENT vs 15.9% on placebo)
The most common side effects in patients
with prurigo nodularis include eye and eyelid
inflammation, including redness, swelling,
and itching, sometimes with blurred vision,
herpes virus infections, common cold
symptoms (nasopharyngitis), dizziness,
muscle pain, and diarrhea.
NOW FDA APPROVED